Pfizer Seeking Full FDA Approval For COVID-19 Vaccine

Pfizer is asking the FDA for full approval of its COVID-19 vaccine, made in conjunction with BioNTech, for people ages 16 and up.

Today's announcement marks the first time the FDA has been asked to give full approval to any of the vaccines currently in use across the country.

The two-shot Pfizer vaccine has been administered so far only under emergency use authorization with 170 million doses already distributed.

Photo credit: Getty Images North America

Sponsored Content

Sponsored Content